2. >>Business

Deal Making: If I Knew Then What I Know Today

 
• By Mike Ward and Lubna Ahmed

David Chiswell, Jane Dancer and Konstantinos Efthymiopoulos shared lessons they have learnt over the years about deal making at this year's 'If I Knew Then What I Know Today' panel at the AngloNordic meeting in London.

AngloNordic Panel 2017
Biotech pioneers discuss deal making lessons learned • Source: Lubna Ahmed

Risks, regrets and missed opportunities were some of the underlying themes of this year's 'If I Knew Then What I Know Today'panel discussion at the 14th AngloNordic meeting in London. Scrip's Mike Ward spoke to Kymab Ltd.'s chair, David Chiswell; F-Star Biotechnology Ltd.'s chief operating officer, Jane Dancer; and Konstantinos Efthymiopoulos, SynAffix BV's chair, about deal making, lessons learnt and what they wish they had done – or indeed hadn't done.

One thing that F-Star's Dancer wished she had wasted less time on, in her early days of deal making, was financial modelling to the nth degree valuations of early stage...

More from Deals

More from Business

Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma

 
• By Jessica Merrill

The royalty revenue stream acquirer has around 40 products in its portfolio and expects to generate roughly $3bn this year. Head of R&D and investments Marshall Urist talked about the investment strategy at the RBC Healthcare Conference.

Finance Watch: SV Closes Second Dementia Discovery Fund, Exceeding $250m Goal

 
• By Mandy Jackson

Private Company Edition: SV Health Investors revealed the final closing of its second Dementia Discovery Fund. Also, Eikon cut nearly 15% of its staff, Pathos AI raised $365m in series D venture capital and CellCentric completed a $120m series C round, among other financings.

Sanofi Makes Alzheimer’s Bet With Vigil Buy

 
• By Kevin Grogan

The French drugmaker is expanding its neurology activities with the $470m deal.